Guanidyl substitutional tetracycline derivative

An alkyl and amino technology, which is used in the field of anti-infective drugs, preparation, treatment and/or prevention of tetracycline-sensitive diseases, and can solve problems such as unsatisfactory activity of Gram-negative bacteria, pain of patients, inconvenient medication, etc.

Inactive Publication Date: 2010-06-30
SHANDONG XUANZHU PHARMA TECH CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Tigecycline has a broad antibacterial spectrum. It not only has the antibacterial activity of early tetracyclines, but also has antibacterial activity against pathogenic bacteria resistant to tetracyclines due to the efflux mechanism and ribosome protectio...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Guanidyl substitutional tetracycline derivative
  • Guanidyl substitutional tetracycline derivative
  • Guanidyl substitutional tetracycline derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0099] Example 1 [S-(4α, 12aα)]-9-[N'-tert-butylguanidino]methyl-4,7-bis(dimethylamino)-1,4,4a,5,5a, 6, 11, 12a-octahydro -3,10,12,12a-tetrahydroxyl-1,11-dioxo 2-naphthacene carboxamide (compound 1) preparation

[0100] Step 1 [S-(4α,12aα)]-9-aminomethyl-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro - Preparation of 3,10,12,12a-tetrahydroxyl-1,11-dioxo-2-naphthacenecarboxamide

[0101] Put [S-(4α,12aα)]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10 into the reaction flask, 12,12a-Tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide 4.6g (10mmol), add 100ml of trifluoroacetic acid, stir to dissolve, then add 3.6g (20mmol) hydroxymethyl-benzyl carbamate ester (HMBC), stirred at room temperature for 2 d, after the reaction was completed, the reaction mixture was filtered, and the filtrate was concentrated under reduced pressure to remove trifluoroacetic acid. Can be purified by preparative HPLC. 2.0 g of solid compound was obtained, yield: 41%.

[010...

Embodiment 2

[0108] Example 2 [S-(4α, 12aα)]-9-[N'-(N,N-dimethyl)guanidino]methyl-4,7-bis(dimethylamino)-1,4, 4a, 5, 5a, 6, 11, 12a- Preparation of octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide (compound 2)

[0109] Referring to Step 2 of Example 1, cast [S-(4α, 12aα)]-9-aminomethyl-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11, 12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide 12.2g (25mmol), N,N-dimethylcyanamide 3.5g (50mmol ). 6.9 g of the target compound was obtained, yield: 50.0%.

[0110] Molecular formula: C 27 h 36 N 6 o 7 Molecular weight: 556.61 Mass spectrum (m / e): 557 (M+1)

[0111] Elemental analysis: theoretical value: C, 58.26%; H, 6.52%; N, 15.10%

[0112] Found: C, 58.15%; H, 6.65%; N, 15.01%

[0113] 1 H-NMR (600MHz, CDCl 3 ): δ1.45(t, 1H), 1.77(t, 1H), 2.12(s, 1H), 2.28(s, 1H), 2.32(t, 1H), 2.34(s, 6H), 2.38(m, 1H), 2.45(s, 6H), 2.48(d, 1H), 2.71(d, 1H), 2.83(s, 6H), 3.27(d, 1H), 4.03(s, 2H), 5.14(s...

Embodiment 3

[0114] Example 3 [S-(4α, 12aα)]-9-[N'-(N,N-diethyl)guanidino]methyl-4,7-bis(dimethylamino)-1,4, 4a, 5, 5a, 6, 11, 12a- Preparation of octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide (compound 3)

[0115] Referring to Step 2 of Example 1, cast [S-(4α, 12aα)]-9-aminomethyl-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11, 12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-tetracenecarboxamide 12.2g (25mmol), N,N-diethylcyanamide 4.9g (50mmol ). 7.4 g of the target compound was obtained, yield: 50.5%.

[0116] Molecular formula: C 29 h 40 N 6 o 7 Molecular weight: 584.66 Mass spectrum (m / e): 585 (M+1)

[0117] Elemental analysis: theoretical value: C, 59.57%; H, 6.90%; N, 14.37%

[0118] Found: C, 59.47%; H, 7.00%; N, 14.25%

[0119] 1 H-NMR (600MHz, CDCl 3 ): δ1.03(t, 6H), 1.46(t, 1H), 1.75(t, 1H), 2.08(s, 1H), 2.26(s, 1H), 2.29(s, 6H), 2.31(t, 1H), 2.36(m, 1H), 2.46(d, 1H), 2.57(q, 4H), 2.70(d, 1H), 2.83(s, 6H), 3.25(d, 1H), 4.02(s, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of medical technology, in particular to a guanidyl substitutional tetracycline derivative shown by a general formula (I), wherein R2, R2', R3, R4, R4', R5, R6, R6', R7, R8, R9, r9', R10, R11 and R12 are defined in an instruction book; the invention further relates to a preparation method of compounds, and medicine composites containing the compounds and the application of the compounds to treating and/or preventing tetracyclines sensitive diseases, particular for the application of anti-infective drugs.

Description

1. Technical field [0001] The invention belongs to the field of medical technology, and in particular relates to tetracycline derivatives substituted by guanidinium groups, pharmaceutically acceptable salts and isomers thereof, preparation methods of these compounds, and the use of these compounds in the preparation of tetracyclines for the treatment and / or prevention of Sensitive diseases, especially the use of anti-infective drugs. 2. Background technology [0002] Tetracycline antibiotics are a class of oral broad-spectrum antibiotics and semi-synthetic derivatives produced by the fermentation of the actinomycete Streptomyces, against Rickettsia, many Gram-positive bacteria and Gram-negative bacteria, lymphogranuloma venereum The pathogen, the inclusion body conjunctivitis pathogen and the psittacosis pathogen have good pharmacological effects. [0003] The first tetracycline antibiotic was aureomycin isolated from Streptomyces aureus in 1948, followed by the development...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C279/14C07D307/66C07D333/36C07D277/48C07C279/18C07D213/75C07D213/40C07C279/16C07D205/04C07D295/215A61K31/65A61P31/00A61P31/04
Inventor 黄振华张蕙周岩周广连
Owner SHANDONG XUANZHU PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap